Holliston, MA – Digilab, Inc. announces the introduction of the Identity Raman Plate Reader for the high throughput measurement and identification of samples using the Raman spectroscopy. There have been substantial technology advancements in recent years in the miniaturization of spectrometers, data storage, laser technology, robotics and automation. Digilab combined these advancements in the IDENTITY Raman Reader, enabling the high throughput measurement of multiple samples in microtiter plates or slides.

The Identity Raman Reader can be used with 96 or 384 well microtiter plates, glass slides or optional tablet holder. The Identity Raman Reader is fast and accurate, and can measure and analyze samples in a 96-well plate in under 5 minutes. The Identity is configurable with either 532nm or 785 nm laser, has optional plate adaptors for measuring liquids, powders and solid samples, and the Identity software will store data files in compatible formats for many spectral analysis and library search-and-build software packages.

About Digilab, Inc.

Digilab; a global leader in molecular spectroscopy systems for over 40 years focusing on sample preparation, bioinformatics, and detection/analysis tools enabling solutions for the life sciences research and in-vitro diagnostics markets, including pharmaceutical and biotech industries, as well universities and governments.

In September of 2004, Digilab sold its product assets to Varian Inc., Digilab, Inc invested the proceeds of this transaction in a business model focused principally on life science research tools and downstream point of need clinical, safety and security applications.

In June of 2006, Digilab acquired SpectraCode Inc. in West Lafayette, Indiana. This acquisition provides Digilab core competence and products in high growth applications which require the versatility and ease of use of Raman Molecular Spectroscopy.

In November of 2007, Digilab acquired Genomic Solutions (which included Gene Machines, Cartesian, and BioRobotics) and MAIA Scientific. These acquisitions broaden Digilab’s global footprint in both the Life Sciences Research pre-analytics market and its commitment to provide downstream systems and solutions which will have broad application in clinical diagnostics.

Digilab, via a series of acquisitions and partnerships, is implementing this business model. Its vision and strategy is retention/expansion of market awareness as a company with unique and high value products for principally the health sciences markets